![William Fricker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Fricker
Nessuna posizione attualmente
Profilo
William Fricker formerly worked at Immunomedics, Inc., as Controller from 2018 to 2020, Eleison Pharmaceuticals, Inc., as Chief Financial Officer from 2022 to 2023, NRX Pharmaceuticals, Inc., as Chief Financial Officer & Treasurer in 2021, J.
M.
Huber Micropowders, Inc., as VP, Global Controller & Chief Accounting Officer, NeuroTrauma Sciences LLC, as Chief Financial Officer from 2023 to 2024, and Annovis Bio, Inc., as Chief Financial Officer from 2024 to 2025.
Mr. Fricker received his undergraduate degree from The Pennsylvania State University.
Precedenti posizioni note di William Fricker
| Società | Posizione | Fine |
|---|---|---|
| ANNOVIS BIO, INC. | Direttore Finanziario/CFO | 27/03/2025 |
NeuroTrauma Sciences LLC
 NeuroTrauma Sciences LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treat brain injury | Direttore Finanziario/CFO | 01/04/2024 |
Eleison Pharmaceuticals, Inc.
 Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes clinical stage drug candidates for orphan cancers | Direttore Finanziario/CFO | 01/01/2023 |
| NRX PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 30/08/2021 |
| IMMUNOMEDICS, INC. | Comptroller/Controller/Auditor | 01/10/2020 |
Formazione di William Fricker
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
2
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Annovis Bio, Inc.
 Annovis Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders | Health Technology |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eleison Pharmaceuticals, Inc.
Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes clinical stage drug candidates for orphan cancers | Health Technology |
NeuroTrauma Sciences LLC
NeuroTrauma Sciences LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treat brain injury | Health Technology |
NRX Pharmaceuticals, Inc.
 NRX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a molecule pharmaceutical company | Health Technology |
J. M. Huber Micropowders, Inc.
 J. M. Huber Micropowders, Inc. Chemicals: SpecialtyProcess Industries Manufactures chemicals and minerals | Process Industries |
